Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Oxbridge Re Holdings (OXBR) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Oxbridge Re Holdings (OXBR) over the last 12 years, with Q3 2025 value amounting to $61000.0.

  • Oxbridge Re Holdings' Other Operating Expenses fell 757.58% to $61000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 92369.48%. This contributed to the annual value of $254000.0 for FY2024, which is 8014.18% up from last year.
  • Latest data reveals that Oxbridge Re Holdings reported Other Operating Expenses of $61000.0 as of Q3 2025, which was down 757.58% from $2.4 million recorded in Q2 2025.
  • Oxbridge Re Holdings' 5-year Other Operating Expenses high stood at $2.4 million for Q2 2025, and its period low was $20000.0 during Q1 2021.
  • Moreover, its 5-year median value for Other Operating Expenses was $61000.0 (2023), whereas its average is $254352.9.
  • In the last 5 years, Oxbridge Re Holdings' Other Operating Expenses crashed by 9472.76% in 2023 and then soared by 370161.29% in 2025.
  • Over the past 5 years, Oxbridge Re Holdings' Other Operating Expenses (Quarter) stood at $23000.0 in 2021, then surged by 4847.83% to $1.1 million in 2022, then tumbled by 94.64% to $61000.0 in 2023, then grew by 8.2% to $66000.0 in 2024, then fell by 7.58% to $61000.0 in 2025.
  • Its Other Operating Expenses was $61000.0 in Q3 2025, compared to $2.4 million in Q2 2025 and $65000.0 in Q1 2025.